Episode 12: Regenerative Medicine from Biotech Industry Perspective
Manage episode 453463367 series 3572991
Send us a text with your thoughts on this episode!
Join Dr. Karmy for an in-depth interview with Dr. Jennifer Woodell-May who was instrumental in the development of the newest treatment for osteoarthritis.
In this episode, Dr. Woodell-May answers the following questions:
1. How are new autologous and regenerative treatments created?
2. What are some of the obstacles to creating new autologous, cell-based therapies?
3. What does the future hold for this field as seen from the perspective of biotechnology industry insiders?
Tune in to this podcast episode to find out!
Zimmer Biomet: https://nstridecanada.zimmerbiomet.com/
Follow our social media:
Instagram
https://www.instagram.com/karmychronicpain?igsh=cHZycXdzeGhqN2Zn
Facebook
https://www.facebook.com/profile.php?id=61550237320641&mibextid=dGKdO6
Learn more about pain management treatments offered at our clinic: https://karmyclinic.com/
챕터
1. Episode 12: Regenerative Medicine from Biotech Industry Perspective (00:00:00)
2. Dr. Woodell’s Professional Journey into Biotechnology (00:01:00)
3. Innovation Challenges in Regenerative Medicine Research (00:05:37)
4. Discovery of nSTRIDE Approach - Concentrating Anti-Inflammatory Cytokines for Osteoarthritis (00:09:13)
5. Pro-Stride APS Device in Veterinary Medicine (00:12:54)
6. Dr Woodell’s Thoughts on Animal Models in Human Medicine Research (00:16:16)
7. Animal Models for nSTRIDE Studies (Dogs, Horses, Goat, Sheep, Athymic Rats) (00:18:46)
8. Composition of Important Chemical Agents in APS Devices (00:21:00)
9. Comparing Different Regenerative Procedures - Mesenchymal Stem Cells Injections (Bone Marrow vs Lipoaspirates), nSTRIDE, PRP (00:27:04)
10. Challenges with Predicting True Responders of Regenerative Medicine (00:31:44)
11. How Artificial Intelligence Can Be Used in Regenerative Medicine - Global Registry for Osteoarthritis (00:34:10)
12. Predicting the Future of the Biotechnology Field (00:36:28)
13 에피소드